• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性胆汁性肝硬化免疫显性自身抗原PDC-E2人源单克隆抗体的特性鉴定及表位作图

Characterization and epitope mapping of human monoclonal antibodies to PDC-E2, the immunodominant autoantigen of primary biliary cirrhosis.

作者信息

Leung P S, Krams S, Munoz S, Surh C P, Ansari A, Kenny T, Robbins D L, Fung J, Starzl T E, Maddrey W

机构信息

University of California, School of Medicine, Davis 95616.

出版信息

J Autoimmun. 1992 Dec;5(6):703-18. doi: 10.1016/0896-8411(92)90187-u.

DOI:10.1016/0896-8411(92)90187-u
PMID:1283300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2965520/
Abstract

Further to define the epitopes of PDC-E2, the major autoantigen in primary biliary cirrhosis (PBC), we have developed and characterized five human monoclonal antibodies. These antibodies were derived by fusing a regional hepatic lymph node from a patient with PBC with the mouse human heterohybrid cell line F3B6. Previous studies of epitope mapping of PDC-E2 have relied on whole sera and have suggested that the immunodominant epitope lies within the inner lipoyl domain of the molecule. However, selective absorption studies using whole sera and a series of overlapping recombinant peptides of PDC-E2 have suggested that the epitope may also include a large conformational component. Moreover, several laboratories have suggested that autoantibodies against the 2-oxo acids dehydrogenase autoantigens are cross-reactive. The five monoclonal antibodies generated included three IgG2a and two IgM antibodies and were studied for antigen specificity using recombinant PDC-E2, recombinant BCKD-E2, histone, dsDNA, IgG (Fc), collagen and a recombinant irrelevant liver specific control, the F alloantigen. The antibodies were also used to probe blots of human, bovine, mouse and rat mitochondria. Finally, fine specificity was studied by selective ELISA and absorption against overlapping expressing fragments of PDC-E2. All five monoclonals, but none of the other mitochondrial autoantigens were specific for PDC-E2. In fact, although affinity purified antibodies to PDC-E2 from patients with PBC cross-reacted with protein X, the human monoclonals did not, suggesting that protein X contains an epitope distinct from that found on PDC-E2. Additionally, all three IgG2 monoclonals recognized distinct epitopes within the inner lipoyl domain of PDC-E2.

摘要

为进一步确定原发性胆汁性肝硬化(PBC)中的主要自身抗原——丙酮酸脱氢酶复合物E2(PDC-E2)的表位,我们制备并鉴定了5种人源单克隆抗体。这些抗体是通过将一名PBC患者的局部肝淋巴结与小鼠-人异源杂交细胞系F3B6融合而获得的。先前关于PDC-E2表位定位的研究依赖于全血清,提示免疫显性表位位于该分子的内部硫辛酰结构域内。然而,使用全血清和一系列重叠的PDC-E2重组肽进行的选择性吸收研究表明,该表位可能还包括一个较大的构象成分。此外,几个实验室提示,针对2-氧代酸脱氢酶自身抗原的自身抗体具有交叉反应性。所产生的5种单克隆抗体包括3种IgG2a和2种IgM抗体,使用重组PDC-E2、重组支链α-酮酸脱氢酶复合物E2(BCKD-E2)、组蛋白、双链DNA、IgG(Fc)、胶原蛋白以及一种重组无关肝特异性对照——F同种抗原研究了其抗原特异性。这些抗体还用于探测人、牛、小鼠和大鼠线粒体的印迹。最后,通过选择性ELISA以及针对PDC-E2重叠表达片段的吸收来研究精细特异性。所有5种单克隆抗体均对PDC-E2具有特异性,而其他线粒体自身抗原均无此特异性。事实上,尽管从PBC患者中亲和纯化的抗PDC-E2抗体与蛋白X发生交叉反应,但人源单克隆抗体却不会,这表明蛋白X含有与PDC-E2上发现的表位不同的表位。此外,所有3种IgG2单克隆抗体均识别PDC-E2内部硫辛酰结构域内不同的表位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f478/2965520/90d7cf216a61/nihms239169f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f478/2965520/942f3ba6eb20/nihms239169f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f478/2965520/a0228c7fadf3/nihms239169f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f478/2965520/c0c69c1a8072/nihms239169f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f478/2965520/90d7cf216a61/nihms239169f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f478/2965520/942f3ba6eb20/nihms239169f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f478/2965520/a0228c7fadf3/nihms239169f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f478/2965520/c0c69c1a8072/nihms239169f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f478/2965520/90d7cf216a61/nihms239169f4.jpg

相似文献

1
Characterization and epitope mapping of human monoclonal antibodies to PDC-E2, the immunodominant autoantigen of primary biliary cirrhosis.原发性胆汁性肝硬化免疫显性自身抗原PDC-E2人源单克隆抗体的特性鉴定及表位作图
J Autoimmun. 1992 Dec;5(6):703-18. doi: 10.1016/0896-8411(92)90187-u.
2
Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.使用一种设计的三表达杂交克隆来检测针对三种不同硫辛酰结构域的抗线粒体自身抗体。
Hepatology. 1996 Jul;24(1):97-103. doi: 10.1002/hep.510240117.
3
Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.使用重组2-氧代戊二酸脱氢酶复合物对原发性胆汁性肝硬化中2-氧代戊二酸脱氢酶复合物E2成分的自身抗体进行表位作图及反应性研究
Hepatology. 1996 Mar;23(3):436-44. doi: 10.1002/hep.510230307.
4
Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis.小鼠单克隆抗体和人自身抗体与人丙酮酸脱氢酶E2(原发性胆汁性肝硬化的主要线粒体自身抗原)的比较表位图谱分析。
J Immunol. 1990 Apr 1;144(7):2647-52.
5
Differing epitope selection of experimentally-induced and natural antibodies to a disease-specific autoantigen, the E2 subunit of pyruvate dehydrogenase complex (PDC-E2).针对疾病特异性自身抗原——丙酮酸脱氢酶复合体(PDC-E2)的E2亚基,实验诱导抗体和天然抗体的表位选择存在差异。
Int Immunol. 1992 Nov;4(11):1245-53. doi: 10.1093/intimm/4.11.1245.
6
Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display.利用噬菌体展示技术预测原发性胆汁性肝硬化中丙酮酸脱氢酶复合体E2的免疫显性表位
J Immunol. 2000 Mar 15;164(6):3413-9. doi: 10.4049/jimmunol.164.6.3413.
7
Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis.原发性胆汁性肝硬化患者中针对丙酮酸脱氢酶复合物E2亚单位(PDC-E2)和胆管上皮细胞的组合型人类自身抗体的异质性。
Hepatology. 1994 Sep;20(3):574-83.
8
Inhibitory autoantibody to a conformational epitope of the pyruvate dehydrogenase complex, the major autoantigen in primary biliary cirrhosis.针对丙酮酸脱氢酶复合体构象表位的抑制性自身抗体,原发性胆汁性肝硬化中的主要自身抗原。
Clin Immunol Immunopathol. 1991 Sep;60(3):356-70. doi: 10.1016/0090-1229(91)90093-p.
9
Random phage mimotopes recognized by monoclonal antibodies against the pyruvate dehydrogenase complex-E2 (PDC-E2).被抗丙酮酸脱氢酶复合体-E2(PDC-E2)单克隆抗体识别的随机噬菌体模拟表位。
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10949-54. doi: 10.1073/pnas.93.20.10949.
10
Natural and disease associated autoantibodies to the autoantigen, dihydrolipoamide acetyltransferase, recognise different epitopes.针对自身抗原二氢硫辛酰胺乙酰转移酶的天然自身抗体和疾病相关自身抗体识别不同的表位。
J Autoimmun. 1998 Apr;11(2):151-61. doi: 10.1006/jaut.1998.0188.

引用本文的文献

1
The effect of serum IL-2 levels on the prognosis of primary biliary cholangitis-related liver failure and the preliminary exploration of its mechanism.血清 IL-2 水平对原发性胆汁性胆管炎相关肝衰竭预后的影响及机制初探。
Front Immunol. 2022 Sep 8;13:995223. doi: 10.3389/fimmu.2022.995223. eCollection 2022.
2
Autoimmune disease triggered by infection with alphaproteobacteria.由α-变形菌感染引发的自身免疫性疾病。
Expert Rev Clin Immunol. 2009 Jul 1;5(4):369-379. doi: 10.1586/ECI.09.23.
3
Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis.针对二氢硫辛酰胺乙酰转移酶的组合自身抗体,原发性胆汁性肝硬化的主要自身抗原。
Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2527-31. doi: 10.1073/pnas.90.6.2527.

本文引用的文献

1
Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity.肌炎自身抗体抑制组氨酰 - tRNA合成酶:自身免疫模型
Nature. 1983;304(5922):177-9. doi: 10.1038/304177a0.
2
A simple, rapid, and sensitive procedure for the assay of endoproteases using Coomassie brilliant blue G-250.一种使用考马斯亮蓝G - 250测定内蛋白酶的简单、快速且灵敏的方法。
Anal Biochem. 1980 Jun;105(1):202-6. doi: 10.1016/0003-2697(80)90446-7.
3
Easy identification of cDNA clones.cDNA克隆的轻松鉴定。
EMBO J. 1983;2(10):1791-4. doi: 10.1002/j.1460-2075.1983.tb01659.x.
4
Primary biliary cirrhosis.原发性胆汁性肝硬化
Adv Intern Med. 1987;32:359-77.
5
Generation of a protective human monoclonal for the treatment of gram-negative sepsis.生成用于治疗革兰氏阴性败血症的保护性人源单克隆抗体。
Prog Clin Biol Res. 1988;272:383-93.
6
The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis.原发性胆汁性肝硬化患者中针对重组融合线粒体多肽的IgG3和IgM同种型抗线粒体自身抗体占优势。
Hepatology. 1988 Mar-Apr;8(2):290-5. doi: 10.1002/hep.1840080217.
7
Genomic structure and amino acid sequence domains of the human La autoantigen.人类La自身抗原的基因组结构和氨基酸序列结构域
J Biol Chem. 1988 Dec 5;263(34):18043-51.
8
Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase.原发性胆汁性肝硬化的人类M2线粒体自身抗原的一级结构:二氢硫辛酰胺乙酰转移酶
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7317-21. doi: 10.1073/pnas.85.19.7317.
9
Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function.原发性胆汁性肝硬化的自身抗体识别二氢硫辛酰胺乙酰转移酶并抑制酶功能。
J Immunol. 1988 Oct 1;141(7):2321-4.
10
Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.自身免疫性甲状腺疾病患者体内的甲状腺过氧化物酶活性抑制性免疫球蛋白
J Clin Endocrinol Metab. 1989 Apr;68(4):730-4. doi: 10.1210/jcem-68-4-730.